Saba Capital Management, L.P. sold HQL
August 21, 2025 · Form 4 insider transaction
Saba Capital Management, L.P. sold 10,710 shares of Abrdn Life Sciences Investors at $14.07 per share, a transaction worth $150.7K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
10,710
Price
$14.07
Total value
$150.7K
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 21, 2025
Filing dateAugust 25, 2025
Shares owned after3,006,829
OwnershipIndirect
10b5-1 planNo
AmendedNo